Creative Planning
TBPH icon

Creative Planning’s Theravance Biopharma TBPH Stock Holding History

Creative Planning’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378K Buy
22,232
+5,765
+35% +$95.4K ﹤0.01% 3401
2026
Q1 		$267K Buy
16,467
+2,094
+15% +$37K ﹤0.01% 3510
2025
Q4 		$269K Buy
14,373
+923
+7% +$15.3K ﹤0.01% 3327
2025
Q3 		$196K Buy
13,450
+842
+7% +$10.6K ﹤0.01% 3498
2025
Q2 		$139K Buy
+12,608
New +$123K ﹤0.01% 3356
2025
Q1 		– Sell
-603
Closed -$5.67K – 3710
2024
Q4 		$5.67K Buy
+603
New +$5.49K ﹤0.01% 3406
2017
Q1 		– Sell
-835
Closed -$27K – 4901
2016
Q4 		$27K Buy
+835
New +$25.9K ﹤0.01% 2872
2016
Q3 		– Sell
-1,000
Closed -$23K – 4725
2016
Q2 		$23K Hold
1,000
– – ﹤0.01% 2698
2016
Q1 		$19K Hold
1,000
– – ﹤0.01% 2799
2015
Q4 		$16K Hold
1,000
– – ﹤0.01% 2999
2015
Q3 		$11K Buy
+1,000
New +$12.7K ﹤0.01% 3163
2015
Q2 		– Sell
-1,000
Closed -$17K – 2802
2015
Q1 		$17K Buy
+1,000
New +$18.3K ﹤0.01% 2849
2014
Q4 		– Sell
-114
Closed -$3K – 4336
2014
Q3 		$3K Buy
+114
New +$3.31K ﹤0.01% 3538

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Creative Planning's TBPH Position: Q2 2026 in Review

Creative Planning increased its Theravance Biopharma (TBPH) stake by 35% in Q2 2026, buying an estimated $95.4K and bringing the position to 22,232 shares worth $378K. The position accounts for ﹤0.01% of the portfolio, ranked #3401.

Creative Planning first reported a position in TBPH in Q3 2014 and has held it in 13 quarters since. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • Creative Planning held 22,232 shares of Theravance Biopharma worth $378K as of Q2 2026.
  • Creative Planning bought 5,765 Theravance Biopharma shares in Q2 2026, an estimated $95.4K.
  • Theravance Biopharma made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3401 holding.
  • Creative Planning first reported a position in Theravance Biopharma in Q3 2014 and has held it in 13 quarters since.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.